Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CMX 157

Known as: CMX-157, CMX157 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
ABSTRACT HIV pre‐exposure prophylaxis (PrEP) strategies have the potential to prevent millions of incident HIV infections each… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2018
2018
Background: The nucleotide reverse transcriptase inhibitor tenofovir (TFV) is widely administered in a disoproxil prodrug form… Expand
  • figure 2
  • table 1
  • table 3
Is this relevant?
Review
2013
Review
2013
Purpose of reviewA number of investigational antiretroviral drugs in clinical development could alter the future treatment… Expand
Is this relevant?
2010
2010
ABSTRACT CMX157 is a lipid (1-0-hexadecyloxypropyl) conjugate of the acyclic nucleotide analog tenofovir (TFV) with activity… Expand
Is this relevant?
2010
2010
Published Ahead of Print 3 May 2010. 10.1128/AAC.00068-10. 2010, 54(7):2901. DOI: Antimicrob. Agents Chemother. and George R… Expand
  • figure 1
  • table 2
  • table 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Although the acyclic nucleoside phosphonates cidofovir, adefovir and tenofovir are approved for treating human cytomegalovirus… Expand
Is this relevant?
Highly Cited
2007
Highly Cited
2007
9-R-[2-(Phosphonomethoxy)propyl]-adenine (tenofovir) is an acyclic nucleoside phosphonate with antiviral activity against human… Expand
Is this relevant?